[Anti-amebic effect of polyenic antibiotics]

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Amoebiasis, caused by Entamoeba histolytica, remains a significant global health concern.
• Existing treatments have limitations, necessitating the search for novel therapeutic agents.
• Polyenic antibiotics are known for their antifungal properties, but their antiamebic potential is less explored.

Purpose of the Study:

• To evaluate the in vitro antiamebic activity of Soviet-produced polyenic antibiotics against Entamoeba histolytica and Entamoeba moshkovskii.
• To compare the efficacy of these polyenic antibiotics with established antiamebic drugs like emetine and metronidazole.
• To assess the antiamebic potential of novel imidazole derivatives.

Main Methods:

• In vitro testing of 15 different drugs, including levorin, mycoheptin, amphotericin B, amphoglucamine, nystatin, emetine, metronidazole, and imidazole derivatives.
• Determination of the Minimum Inhibitory Concentrations (MICs) for each drug against E. histolytica and E. moshkovskii.
• Comparative analysis of the antiamebic activity of polyenic antibiotics versus other tested agents.

Main Results:

• All tested polyenic antibiotics exhibited significant antiamebic activity.
• Levorin and its derivatives displayed the highest potency, with MICs ranging from 0.1 to 5.38 µg/ml.
• The most effective new imidazole derivative was 100 times less potent than sodium levorin.
• Polyenic antibiotics demonstrated a broad antiprotozoal spectrum.

Conclusions:

• Polyenic antibiotics possess considerable antiamebic activity.
• Levorin and its derivatives represent promising candidates for amoebiasis treatment.
• These findings suggest a broader therapeutic application for polyenic antibiotics beyond antifungal uses.